Advisory Services Network’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
Advisory Services Network's AGIO Position: Q2 2026 in Review
Advisory Services Network sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 350 shares — an estimated $11.8K sold.
Advisory Services Network first reported a position in AGIO in Q1 2017 and held it in 21 quarters. The position peaked at $48K in Q4 2019. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Advisory Services Network reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 350 Agios Pharmaceuticals shares in Q2 2026, an estimated $11.8K.
- Advisory Services Network first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 21 quarters.
- Advisory Services Network's Agios Pharmaceuticals position peaked at $48K in Q4 2019.
- 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.